[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
cloudwalker posts on X about $vktx, $nvo, $lly, $pfe the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXX% finance XXXX% currencies XXXX%
Social topic influence $vktx 2.22%, $nvo 2.22%, $lly 2.22%, $pfe 2.22%, $600m 2.22%, $mtsr 2.22%, $mrk 2.22%, $6b 2.22%, $73b 2.22%, $2b XXXX%
Top accounts mentioned or mentioned by @pharmdca @bioinvestor24 @wyv123 @msollender @jayabacus @dan85281670 @pbbanerjee @capitalvennett @musicalxmadn909 @norriharb @jul05310473john @informedvolume @1976hank @maugusterfer @doctor_salomon @hothomaswphelps @thetwitabides
Top assets mentioned Viking Therapeutics, Inc (VKTX) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Metsera, Inc. Common Stock (MTSR) Merck & Co., Inc. (MRK) AstraZeneca PLC (AZN) Akropolis (AKRO)
Top posts by engagements in the last XX hours
"$vktx $nvo $lly $pfe Obesity: Kailera raised $600M in series B (Kailera licensed GLP from its parent company Hengrui for $6B) $mtsr Metsera got bought at $7.3B $mrk Hansoh preclinical deal at $2B $AZN Eccogene's deal at $2B $RHHBY Roche bought Carmot at $2.7B Roche partnered with Zealand for $5.6B MASH: $akro Akero bought at $5.2B $etnb 89bio bought at $3.5B Boston pharma bought at $2B"
X Link @cloud_walker200 2025-10-14T13:46Z XXX followers, 1182 engagements